Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New guidelines recommend focusing on healthy foods but don’t restrict added sugars or alcohol as much as some experts had hoped.
This may reflect loss of the weight-suppressing effect of the older version of the drug.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Overweight and obesity are linked to a host of health problems.
Twelve states have an adult obesity prevalence of 35% or more.
Age, underlying medical conditions, race/ethnicity and economic status all play a role in determining the risk for severe illness.
“Will we have a COVID vaccine next year tailored to the obese? No way."
The effect is greater for women, and it could have a detrimental effect on pregnancy outcomes at the population level.
This finding held true regardless of individuals’ initial weight, unless they had obesity, in a recent large study.
Having an undetectable viral load did not change the risk, which nevertheless was not as severe as the risk tied to diabetes.
Newer drug classes are tied to a higher risk of weight gain, which is more likely to occur among Black women in particular.
Researchers at George Washington University take a look.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
HIV is associated with an elevated risk of diabetes.
Researchers have for the first time properly assessed HIV’s association with this health outcome.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.